These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12735648)

  • 1. Severe mucocutaneous necrotizing vasculitis associated with the combination of chloroquine and proguanil.
    Luong MS; Bessis D; Raison-Peyron N; Pinzani V; Guilhou JJ; Guillot B
    Acta Derm Venereol; 2003; 83(2):141. PubMed ID: 12735648
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute generalized exanthematous pustulosis due to the combination of chloroquine and proguanil.
    Janier M; Froidevaux D; Lons-Danic D; Daniel F
    Dermatology; 1998; 196(2):271. PubMed ID: 9568425
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of atovaquone-proguanil chemoprophylaxis and chloroquine treatment in Plasmodium malariae infection.
    Visser R; de Mast Q; Munnix I; van der Ven A; Dofferhoff T
    Travel Med Infect Dis; 2016; 14(6):644-645. PubMed ID: 27546283
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic effect of Malarone against malaria: all good news?
    Nosten F
    Lancet; 2000 Dec; 356(9245):1864-5. PubMed ID: 11130375
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe hypersensitivity reaction as acute eosinophilic pneumonia and skin eruption induced by proguanil.
    Just N; Carpentier O; Brzezinki C; Steenhouwer F; Staumont-Sallé D
    Eur Respir J; 2011 Jun; 37(6):1526-8. PubMed ID: 21632832
    [No Abstract]   [Full Text] [Related]  

  • 6. [Duodenal ulcers caused by chloroquine-proguanil association].
    Roux X; Imbert P; Rivière F; Méchaï F; Rapp C
    Med Trop (Mars); 2010 Dec; 70(5-6):423-4. PubMed ID: 21520638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatotoxicity associated with the use of a fixed combination of chloroquine and proguanil.
    Wielgo-Polanin R; Lagarce L; Gautron E; Diquet B; Lainé-Cessac P
    Int J Antimicrob Agents; 2005 Aug; 26(2):176-8. PubMed ID: 16009537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation.
    Davis TM
    Ann Pharmacother; 1998 Oct; 32(10):1104-6. PubMed ID: 9793605
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epileptic crisis after antimalaria chemoprophylaxis with chloroquine].
    Guilloton L; Burckard E; Fresse S; Drouet A; Felten D
    Presse Med; 2001 Nov; 30(35):1745. PubMed ID: 11769070
    [No Abstract]   [Full Text] [Related]  

  • 10. [Severe skin disease induced by a chloroquine-proguanil combination].
    Cipriano G; Djossou F; Sibaud V; Geniaux M; Malvy D; Le Bras M; Taieb A
    Therapie; 2001; 56(1):59-61. PubMed ID: 11322020
    [No Abstract]   [Full Text] [Related]  

  • 11. Side effects of mefloquine prophylaxis for malaria: an independent randomized controlled trial.
    Croft AM; Clayton TC; World MJ
    Trans R Soc Trop Med Hyg; 1997; 91(2):199-203. PubMed ID: 9196769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria chemoprophylaxis.
    Milord F; Allard R; Gyorkos TW
    Lancet; 1993 Aug; 342(8869):502. PubMed ID: 8102463
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs for preventing malaria in travellers.
    Jacquerioz FA; Croft AM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pustular eruption in a malaria patient treated with chloroquine.
    Wilairatana P; Looareesuwan S; Riganti M; Teja-Isavadharm P; Keeratithakul D; Eickmeyer S; Walsh DS
    Int J Dermatol; 1997 Aug; 36(8):634-5. PubMed ID: 9329900
    [No Abstract]   [Full Text] [Related]  

  • 15. Pustular eruption in a malaria patient treated with chloroquine.
    Wilairatana P; Looareesuwan S; Riganti M; Teja-Isavadharm P; Keeratithakul D; Eickmeyer S; Walsh DS
    Int J Dermatol; 1998 Sep; 37(9):713-4. PubMed ID: 9762829
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term chloroquine-proguanil malaria prophylaxis in a nonimmune pediatric population.
    Gozal D; Fadat G; Hengy C
    J Pediatr; 1991 Jan; 118(1):142-5. PubMed ID: 1986083
    [No Abstract]   [Full Text] [Related]  

  • 17. Malaria prophylaxis for long term visitors.
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1454-5. PubMed ID: 6416455
    [No Abstract]   [Full Text] [Related]  

  • 18. Atovaquone and proguanil hydrochloride.
    Am J Health Syst Pharm; 2000 Dec; 57(23):2165-6. PubMed ID: 11127694
    [No Abstract]   [Full Text] [Related]  

  • 19. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
    Camus D; Djossou F; Schilthuis HJ; Høgh B; Dutoit E; Malvy D; Roskell NS; Hedgley C; De Boever EH; Miller GB;
    Clin Infect Dis; 2004 Jun; 38(12):1716-23. PubMed ID: 15227617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.